MedTrace Logo

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

NCT04543422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-09-10

No results posted yet for this study

Summary

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DIETARY_SUPPLEMENT

Green tea

Green tea extract capsules

OTHER

Placebo

Placebo containing inert material.

Sponsors & Collaborators

  • Egyptian Biomedical Research Network

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04543422 on ClinicalTrials.gov